Study Links Cold Sores to Alzheimer’s Disease

A recent study in BMJ Open suggests that cold sores might be implicated in the development of Alzheimer’s disease. Researchers analyzed data from 344,628 pairs of individuals, matched by age, gender, region, and healthcare visits, where one had Alzheimer’s and the other did not.

In this study, 1,507 individuals with Alzheimer’s also carried the herpes simplex virus type 1 (HSV-1), while only 823 in the control group had the virus. Among the 2,330 individuals examined, about 40% used antiviral treatments after their diagnosis.

Those who received antiviral therapy were found to be 17% less likely to develop Alzheimer’s compared to those who didn’t use such treatments. This finding sheds some light on the potential for managing risk factors associated with this form of dementia.

As we know, age is a significant risk factor for dementia, but what’s striking is that the likelihood of being diagnosed with HSV-1 was found to be 80% higher in those with Alzheimer’s. While HSV-2 can also cause complications, HSV-1 is more commonly noted in these cases.

The researchers emphasized the importance of treating herpes virus as a public health priority. It’s a little concerning that women made up around 65% of the Alzheimer’s cases in the study, with an average age of 73. They often had additional health conditions that could further complicate matters.

The study also explored other herpes viruses, pointing out that some of them correlate with an increased risk of Alzheimer’s. The intricacies of how viruses like HSV-1 might lead to dementia remain unclear, yet the team indicated that inflammation in the brain due to viral infections could play a crucial role.

While there isn’t a cure for herpes, proper treatment can manage outbreaks effectively. Antiviral drugs or topical creams can shorten recovery times and lessen the severity of future outbreaks. Yet, the study does acknowledge some limitations. For instance, it didn’t account for HSV-1 infections that were documented prior to patients’ entries into the database, which may result in an incomplete picture.

Moreover, many people infected with HSV-1 might not show symptoms and may not seek medical attention during flare-ups, leading to potential underreporting in clinical data. It’s estimated that about two-thirds of individuals under 50 carry HSV-1, but information on symptomatic cases is somewhat sparse.

Finally, the lack of a formal Alzheimer’s diagnosis can skew the results, adding another layer of complexity to this ongoing research. Fox News Digital is currently seeking further insights from researchers and healthcare professionals regarding these findings.